Skip to main content

Table 2 Tumor uptake of [ 11 C]ACE and [ 11 C]MTO in different study groups

From: Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate

Group

[ 11C]ACE

[ 11C]MTO

 

SUV max

SUV mean

T/L

SUV max

SUV mean

T/L

Group I (HCC; n = 14)

8.17 ± 3.03

5.68 ± 2.06

1.44 ± 0.75*

9.84 ± 6.36

6.43 ± 4.68

1.19 ± 0.81

Group II (FNH; n = 9)

7.36 ± 3.51

5.27 ± 2.44*

1.25 ± 0.31

12.82 ± 5.23

9.93 ± 3.61

1.51 ± 0.32*

Group III (other liver tumors; n = 10)

5.67 ± 3.16

4.21 ± 2.48

0.75 ± 0.28

7.76 ± 4.62

5.78 ± 3.90

0.75 ± 0.39

  1. Results are expressed as mean ± SD. SUV, standardized uptake value; T/L, tumor-to-liver ratio. * P < 0.05 versus group III (unpaired t test).